Cargando…

A novel mechanism for immune regulation after human lung transplantation

OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanakumar, Thalachallour, Sharma, Monal, Bansal, Sandhya, Ravichandran, Ranjithkumar, Smith, Michael A., Bremner, Ross M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The American Association for Thoracic Surgery 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625531/
https://www.ncbi.nlm.nih.gov/pubmed/31288367
http://dx.doi.org/10.1016/j.jtcvs.2018.12.105
_version_ 1783434432744521728
author Mohanakumar, Thalachallour
Sharma, Monal
Bansal, Sandhya
Ravichandran, Ranjithkumar
Smith, Michael A.
Bremner, Ross M.
author_facet Mohanakumar, Thalachallour
Sharma, Monal
Bansal, Sandhya
Ravichandran, Ranjithkumar
Smith, Michael A.
Bremner, Ross M.
author_sort Mohanakumar, Thalachallour
collection PubMed
description OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune responses that lead to bronchiolitis obliterans syndrome. METHODS: We collected blood from patients who underwent lung transplant at our institution. Exosomes were isolated from the sera of recipients with risk factors for chronic rejection and from stable recipients. Exosomes were analyzed with western blot, using antibodies to lung self-antigens K alpha 1 tubulin and collagen-V, costimulatory molecules (costimulatory molecule 80, costimulatory molecule 86), transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells, hypoxia-inducible factor 1α, Class II Major Histocompatibility Complex Transactivator), and 20S proteasome. RESULTS: Of the 90 patients included, we identified 5 with grade 3 primary graft dysfunction, 5 without, 15 with respiratory viral infection, 10 with acute rejection, 10 with donor-specific antibodies (DSA), 5 without DSA, and 10 who were stable for exosome isolation. Recipients with grade 3 primary graft dysfunction, respiratory viral infection, acute rejection, and DSA had exosomes containing self-antigens; exosomes from stable recipients did not. Exosomes from recipients with grade 3 primary graft dysfunction, acute rejection, and DSA also demonstrated costimulatory molecule 80, costimulatory molecule 86, major histocompatibility complex class II, transcription factor, and 20S proteasome. CONCLUSIONS: Transplanted lungs with grade 3 primary graft dysfunction, symptomatic respiratory viral infection, acute rejection, and immune responses induce exosomes that contain self-antigens, costimulatory molecules, major histocompatibility complex class II, transcription factors, and 20S proteasome. Release of circulating exosomes post-transplant from the aforementioned stress-inducing insults augment immunity and may play an important role in the pathogenesis of bronchiolitis obliterans syndrome.
format Online
Article
Text
id pubmed-6625531
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher by The American Association for Thoracic Surgery
record_format MEDLINE/PubMed
spelling pubmed-66255312020-03-25 A novel mechanism for immune regulation after human lung transplantation Mohanakumar, Thalachallour Sharma, Monal Bansal, Sandhya Ravichandran, Ranjithkumar Smith, Michael A. Bremner, Ross M. J Thorac Cardiovasc Surg Article OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune responses that lead to bronchiolitis obliterans syndrome. METHODS: We collected blood from patients who underwent lung transplant at our institution. Exosomes were isolated from the sera of recipients with risk factors for chronic rejection and from stable recipients. Exosomes were analyzed with western blot, using antibodies to lung self-antigens K alpha 1 tubulin and collagen-V, costimulatory molecules (costimulatory molecule 80, costimulatory molecule 86), transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells, hypoxia-inducible factor 1α, Class II Major Histocompatibility Complex Transactivator), and 20S proteasome. RESULTS: Of the 90 patients included, we identified 5 with grade 3 primary graft dysfunction, 5 without, 15 with respiratory viral infection, 10 with acute rejection, 10 with donor-specific antibodies (DSA), 5 without DSA, and 10 who were stable for exosome isolation. Recipients with grade 3 primary graft dysfunction, respiratory viral infection, acute rejection, and DSA had exosomes containing self-antigens; exosomes from stable recipients did not. Exosomes from recipients with grade 3 primary graft dysfunction, acute rejection, and DSA also demonstrated costimulatory molecule 80, costimulatory molecule 86, major histocompatibility complex class II, transcription factor, and 20S proteasome. CONCLUSIONS: Transplanted lungs with grade 3 primary graft dysfunction, symptomatic respiratory viral infection, acute rejection, and immune responses induce exosomes that contain self-antigens, costimulatory molecules, major histocompatibility complex class II, transcription factors, and 20S proteasome. Release of circulating exosomes post-transplant from the aforementioned stress-inducing insults augment immunity and may play an important role in the pathogenesis of bronchiolitis obliterans syndrome. by The American Association for Thoracic Surgery 2019-05 2019-02-12 /pmc/articles/PMC6625531/ /pubmed/31288367 http://dx.doi.org/10.1016/j.jtcvs.2018.12.105 Text en © 2019 by The American Association for Thoracic Surgery. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mohanakumar, Thalachallour
Sharma, Monal
Bansal, Sandhya
Ravichandran, Ranjithkumar
Smith, Michael A.
Bremner, Ross M.
A novel mechanism for immune regulation after human lung transplantation
title A novel mechanism for immune regulation after human lung transplantation
title_full A novel mechanism for immune regulation after human lung transplantation
title_fullStr A novel mechanism for immune regulation after human lung transplantation
title_full_unstemmed A novel mechanism for immune regulation after human lung transplantation
title_short A novel mechanism for immune regulation after human lung transplantation
title_sort novel mechanism for immune regulation after human lung transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625531/
https://www.ncbi.nlm.nih.gov/pubmed/31288367
http://dx.doi.org/10.1016/j.jtcvs.2018.12.105
work_keys_str_mv AT mohanakumarthalachallour anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT sharmamonal anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT bansalsandhya anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT ravichandranranjithkumar anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT smithmichaela anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT bremnerrossm anovelmechanismforimmuneregulationafterhumanlungtransplantation
AT mohanakumarthalachallour novelmechanismforimmuneregulationafterhumanlungtransplantation
AT sharmamonal novelmechanismforimmuneregulationafterhumanlungtransplantation
AT bansalsandhya novelmechanismforimmuneregulationafterhumanlungtransplantation
AT ravichandranranjithkumar novelmechanismforimmuneregulationafterhumanlungtransplantation
AT smithmichaela novelmechanismforimmuneregulationafterhumanlungtransplantation
AT bremnerrossm novelmechanismforimmuneregulationafterhumanlungtransplantation